Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Equity (2018 - 2025)

Bicycle Therapeutics' Return on Equity history spans 8 years, with the latest figure at 0.01% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 1.0% down from the prior year.
  • Return on Equity reached 0.01% in Q4 2025 per BCYC's latest filing, up from 0.11% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q4 2024 to a low of 0.63% in Q2 2023.
  • Average Return on Equity over 5 years is 0.3%, with a median of 0.3% recorded in 2022.
  • Peak YoY movement for Return on Equity: crashed -35bps in 2023, then surged 46bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.26% in 2021, then plummeted by -63bps to 0.42% in 2022, then dropped by -7bps to 0.45% in 2023, then surged by 103bps to 0.01% in 2024, then dropped by -29bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Return on Equity are 0.01% (Q4 2025), 0.11% (Q3 2025), and 0.09% (Q2 2025).